| Participants (n = 185) | Declined (n = 239) | Analysis |
---|---|---|---|
Gender Male (%) | 52.4 | 50.2 | χ2 = 0.2, 1df p = 0.65 |
Age (years) | 68 ± 12.6 | 68.3 ± 13.1 | t = 0.12, p = 0.9 |
Cancer diagnosis (%) | Â | Â | Â |
Bronchial | 18.4 | 23.4 | χ2 = 5.7, |
Breast | 14.1 | 12.1 | 9df |
Lower GI | 14.1 | 13.8 | p = 0.8 |
Upper GI | 11.4 | 10.9 | Â |
Prostate | 9.7 | 7.1 | Â |
Gynaecological | 7 | 6.3 | Â |
Pancreatic/hepatobiliary | 6.5 | 8.8 | Â |
Urological not prostate | 5.4 | 4.6 | Â |
Brain | 2.7 | 0.8 | Â |
Other | 10.8 | 12.1 | Â |